TCIM
TCRT icon

TIAA CREF Investment Management’s Alaunos Therapeutics TCRT Stock Holding History

TIAA CREF Investment Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$975K Sell
1,688
-135
-7% -$56.4K ﹤0.01% 2326
2018
Q4 		$511K Sell
1,823
-11
-0.6% -$4.35K ﹤0.01% 2556
2018
Q3 		$880K Sell
1,834
-67
-4% -$28.7K ﹤0.01% 2481
2018
Q2 		$861K Sell
1,901
-138
-7% -$87.5K ﹤0.01% 2553
2018
Q1 		$1.2M Buy
2,039
+16
+0.8% +$9.97K ﹤0.01% 2343
2017
Q4 		$1.26M Sell
2,023
-281
-12% -$202K ﹤0.01% 2351
2017
Q3 		$2.12M Sell
2,304
-32
-1% -$28.4K ﹤0.01% 2134
2017
Q2 		$2.18M Buy
2,336
+149
+7% +$146K ﹤0.01% 2127
2017
Q1 		$2.08M Sell
2,187
-521
-19% -$485K ﹤0.01% 2126
2016
Q4 		$2.17M Sell
2,708
-143
-5% -$129K ﹤0.01% 2143
2016
Q3 		$2.41K Sell
2,851
-201
-7% -$162K ﹤0.01% 2068
2016
Q2 		$2.51M Buy
3,052
+70
+2% +$76.2K ﹤0.01% 1982
2016
Q1 		$3.32M Buy
2,982
+128
+4% +$131K ﹤0.01% 1773
2015
Q4 		$3.56M Buy
2,854
+333
+13% +$551K ﹤0.01% 1796
2015
Q3 		$3.41M Sell
2,521
-71
-3% -$117K ﹤0.01% 1810
2015
Q2 		$4.67M Buy
2,592
+451
+21% +$700K ﹤0.01% 1732
2015
Q1 		$3.46M Buy
2,141
+99
+5% +$147K ﹤0.01% 1876
2014
Q4 		$1.55M Sell
2,042
-109
-5% -$57.9K ﹤0.01% 2403
2014
Q3 		$852K Sell
2,151
-75
-3% -$36.2K ﹤0.01% 2729
2014
Q2 		$1.34M Buy
2,226
+86
+4% +$47.9K ﹤0.01% 2542
2014
Q1 		$1.47M Sell
2,140
-58
-3% -$38.9K ﹤0.01% 2423
2013
Q4 		$1.43M Buy
2,198
+518
+31% +$308K ﹤0.01% 2453
2013
Q3 		$995K Sell
1,680
-343
-17% -$155K ﹤0.01% 2605
2013
Q2 		$637K Buy
+2,023
New +$562K ﹤0.01% 2850

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TIAA CREF Investment Management's TCRT Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Alaunos Therapeutics (TCRT) stake by 7.4% in Q1 2019, selling an estimated $56.4K and leaving 1,688 shares worth $975K. The position accounts for ﹤0.01% of the portfolio, ranked #2326.

TIAA CREF Investment Management first reported a position in TCRT in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.67M in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q1 2019.

  • TIAA CREF Investment Management held 1,688 shares of Alaunos Therapeutics worth $975K as of Q1 2019.
  • TIAA CREF Investment Management sold 135 Alaunos Therapeutics shares in Q1 2019, an estimated $56.4K.
  • Alaunos Therapeutics made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2326 holding.
  • TIAA CREF Investment Management first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Alaunos Therapeutics position peaked at $4.67M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.